George Donato
Chief Operating Officer chez OYSR POIN
Profil
George Donato is currently working as Senior Vice President-Operations & CMC at Oyster Point Pharma, Inc. He previously worked as Senior Vice President-Operations at Iroko Pharmaceuticals, Inc. He completed his undergraduate degree and MBA from Widener University.
Postes actifs de George Donato
| Sociétés | Poste | Début |
|---|---|---|
| OYSR POIN | Chief Operating Officer | - |
Anciens postes connus de George Donato
| Sociétés | Poste | Fin |
|---|---|---|
Iroko Pharmaceuticals, Inc.
 Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA. | Chief Operating Officer | - |
Formation de George Donato
| Widener University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Iroko Pharmaceuticals, Inc.
Iroko Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals, Inc. develops and distributes pharmaceutical products. Its products include Indocin and Aldomet. The company was founded on January 18, 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
